SFRP2 and hepatocellular carcinoma: Moreover, in spite of the near ubiquitous Wnt pathway activation [14,15] and possible epigenetic silencing of Wnt inhibitors, especially SFRP2 and DKK1 in HCC [21-24], very limited data is available regarding methylation of these loci in HCV infected non-cancerous patients.